Not exact matches
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation
status for improved
lung cancer patient management.
Ceritinib significantly improved
patient - reported outcomes including
lung cancer - specific symptoms and overall health
status, compared to placebo (p < 0.05).
«First - line immunotherapy treatment can improve survival for subset of
lung cancer patients: Results of phase III global clinical trial show that 75 percent of stage IV
lung cancer patients with both complex tumor mutations and PDL - 1 positive
status respond to nivolumab.»
Gromova, E. G., et al. «[Regulation of the indices of neuroendocrine
status in surgical
patients with
lung cancer using optimal doses of ascorbic acid].»